Fraunhofer-Gesellschaft

Publica

Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Assessment of in vitro COPD models for tobacco regulatory science: Workshop proceedings, conclusions and paths forward for in vitro model use

 
: Behrsing, H.; Raabe, H.; Manuppello, J.; Bombick, B.; Curren, R.; Sullivan, K.; Sethi, S.; Phipps, R.; Tesfaigzi, Y.; Yan, S.; D'Ruiz, C.; Tarran, R.; Constant, S.; Phillips, G.; Gaca, M.; Hayden, P.; Cao, X.; Mathis, C.; Hoeng, J.; Braun, A.; Hill, E.

Alternatives to laboratory animals : ATLA 44 (2016), No.2, pp.129-166
ISSN: 0261-1929
English
Journal Article
Fraunhofer ITEM ()
COPD; in vitro; in vitro lung; in vitro model; pulmonary model; tobacco regulatory science

Abstract
The Family Smoking Prevention and Tobacco Control Act of 2009 established the Food and Drug Administration Center for Tobacco Products (FDA-CTP), and gave it regulatory authority over the marketing, manufacture and distribution of tobacco products, including those termed 'modified risk'. On 8-10 December 2014, IIVS organised a workshop conference, entitled Assessment of In Vitro COPD Models for Tobacco Regulatory Science, to bring together stakeholders representing regulatory agencies, academia, industry and animal protection, to address the research priorities articulated by the FDA-CTP. Specific topics were covered to assess the status of current in vitro technologies as they are applied to understanding the adverse pulmonary events resulting from tobacco product exposure, and in particular, the progression of chronic obstructive pulmonary disease (COPD).

: http://publica.fraunhofer.de/documents/N-421951.html